Merck Offers No Guidance (MRK)
July 22nd, 2008

Merck (MRK) has pulled the plug on earnings guidance for the rest of the year. The company reported its numbers last night, and management backed off of previous goals that were set, with embattled cholesterol drug Vytorin being a factor in the company's revenue guidance.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!



Stock Screener
RSS

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the